WebThe farnesoid-X-receptor (FXR) is validated target in the cholestatic disorders treatment. Obeticholic acid (OCA), the first in class of FXR agonist approved for clinical use, causes side effects including acute liver decompensation when administered to cirrhotic patients with primary biliary cholan … WebConclusion: We have identified an FXR/β-catenin interaction whose modulation through β-catenin suppression promotes FXR activation and decreases hepatic BAs, which may provide unique therapeutic opportunities in cholestatic liver diseases. (Hepatology 2024;67:955-971). © 2024 by the American Association for the Study of Liver Diseases.
Mast Cells Regulate Ductular Reaction and Intestinal ... - PubMed
WebApr 4, 2024 · Cholestasis is a common complication of sepsis, and the increased plasma levels of bile acids are predictive of sepsis-associated mortality. However, the exact mechanism by which cholestasis aggravates sepsis development remains elusive. Here, we show that bile acids are danger-associated molecular … WebThe nuclear receptor farnesoid X receptor (FXR) plays an important role in physiological bile acid synthesis, secretion and transport. Defects of FXR regulation in these processes can cause cholestasis and subsequent pathological changes. FXR regulates the synthesis and uptake of bile acid via enzymes. building affordable homes with help
Role of farnesoid X receptor in cholestasis - PubMed
WebRubicon, which inhibits autophago-lysosomal maturation, was identified as a direct FXR target that is induced in cholestasis and by FXR-agonistic bile acids. Genetic inhibition … WebAbstract. Introduction: Bile acids, the end product of cholesterol metabolism, are signaling molecules. The farnesoid X receptor (FXR) is a bile acid sensor and is part of a … WebApr 1, 2024 · Ileal farnesoid X receptor (FXR) controls bile acid transport across the intestinal epithelial cells into the blood where systemic bile acid metabolites influence inflammation, glucose homeostasis, obesity, insulin resistance, and NAFLD. ... Cholestasis and hepatic fibrosis patients decrease P. distasonis levels and BSH activity. a ... building a fence to keep deer out